A pulmonary innate lymphoid cell-driven serotonergic neuroimmune axis orchestrates airway hyperreactivity and cough hypersensitivity

Study limitation reported by the research below: “The 'practice changing' impact flag is applied cautiously: the mechanistic findings are novel and the serotonergic pathway is a credible therapeutic target, but no clinical intervention data exist yet.”